Leaderboards/Viral Infections and Outbreaks Research

Viral Infections and Outbreaks Research

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Shruti Khare
Agency for Science, Technology and Research
2
Michael I. Barton
University of Oxford
3
Changshuo Wei
Chinese Academy of Sciences
4
Ariadna E. Morales
Goethe University Frankfurt
5
Zhiyuan Chen
Fudan University
6
Esther Nakkazi
Community Health And Information Network
7
Kushal Suryamohan
SciGenom Labs (India)
8
Ngashi Ngongo
Africa Centres for Disease Control and Prevention
9
Haruka Kemmoku
Tohoku University
10
Bianca S. Bodmer
Friedrich-Loeffler-Institut

Papers

1
Publication in Science (2024) [99 citations, W4404125088]
Science|2024
99 cit.
2
Publication in Nature (2025) [56 citations, W4406956854]
Nature|2025
56 cit.
3
Publication in Nature Microbiology (2024) [17 citations, W4398240093]
Nature Microbiology|2024
17 cit.
4
Publication in Molecular Biology and Evolution (2024) [12 citations, W4401476157]
Molecular Biology and Evolution|2024
12 cit.
5
Ligand requirements for immunoreceptor triggering
Communications Biology|2024
0 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Gemma Buckland‐Merrett
Pfizer (United States)
2
Ingra Morales Claro
Universidade de São Paulo
3
Seth Flaxman
University of Oxford
4
Darlan da Silva Cândido
Universidade Brasil
5
Thomas A. Mellan
Imperial College London
6
Alina Baum
Regeneron (United States)
7
Godelieve J. de Bree
University Medical Center
8
Karlijn van der Straten
Amsterdam University Medical Centers
9
Tom G. Caniels
Amsterdam University Medical Centers
10
Salihu S. Musa
University of Maryland, College Park

Papers

1
Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the US
JAMA Network Open|2023
140 cit.
2
Antigenic cartography using sera from sequence-confirmed SARS-CoV-2 variants of concern infections reveals antigenic divergence of Omicron
Immunity|2022
99 cit.
3
Germline-targeting HIV-1 Env vaccination induces VRC01-class antibodies with rare insertions
Cell Reports Medicine|2023
54 cit.
4
Shotgun metagenomic sequencing of the first case of monkeypox virus in Brazil, 2022
Revista do Instituto de Medicina Tropical de São Paulo|2022
41 cit.
5
Precise targeting of HIV broadly neutralizing antibody precursors in humans
Science|2025
41 cit.
6
Germline-targeting HIV vaccination induces neutralizing antibodies to the CD4 binding site
Science Immunology|2024
39 cit.
7
Using deep convolutional neural networks to forecast spatial patterns of Amazonian deforestation
Methods in Ecology and Evolution|2022
33 cit.
8
The Heterogeneous Severity of COVID-19 in African Countries: A Modeling Approach
Bulletin of Mathematical Biology|2022
27 cit.
9
Infection fatality rate and infection attack rate of COVID-19 in South American countries
Infectious Diseases of Poverty|2022
26 cit.
10
Unwillingness or reluctance of Palestinians to get the COVID-19 vaccine: the reasons behind it and how to persuade them
International Journal of Infectious Diseases|2022
23 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Stefan Pöhlmann
German Primate Center
2
Heinz Feldmann
National Institutes of Health
3
David Veesler
Howard Hughes Medical Institute
4
Yoshihiro Kawaoka
University of Wisconsin–Madison
5
Sina Bavari
Epix Pharmaceuticals (United States)
6
Stephan Günther
Bernhard Nocht Institute for Tropical Medicine
7
Thomas W. Geisbert
The University of Texas Medical Branch at Galveston
8
Pierre E. Rollin
Université Claude Bernard Lyon 1
9
Erica Ollmann Saphire
La Jolla Institute for Immunology
10
Stuart T. Nichol
Centers for Disease Control and Prevention

Papers

1
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Cell|2020
21.4k cit.
2
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Cell|2020
9.1k cit.
3
Evolution and ecology of influenza A viruses.
Microbiological Reviews|1992
2.2k cit.
4
A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
Molecular Cell|2020
2.1k cit.
5
Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
Cell|2020
1.6k cit.
6
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Nature|2016
1.6k cit.
7
Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
Nature|2012
1.6k cit.
8
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein
Cell|2020
1.5k cit.
9
Influenza virus receptors in the human airway
Nature|2006
1.4k cit.
10
Emergence of Zaire Ebola Virus Disease in Guinea
New England Journal of Medicine|2014
1.4k cit.

Reagents for Viral Infections and Outbreaks Research

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 66

SF3B4 (E7R4H) Rabbit Monoclonal Antibody

Cited in 7 papers
#68862$175,376
View Evidence →
Cell Signaling TechnologyEvidence 65

IFIT1 (D2X9Z) Rabbit Monoclonal Antibody

Cited in 6 papers
#14769$159,352
View Evidence →
Cell Signaling TechnologyEvidence 73

CD2 (D6V9F) Rabbit Monoclonal Antibody

Cited in 6 papers
#9987$168,369
View Evidence →

🌟 All-Time

Most validated

ProteintechEvidence 69

TMEM173/STING Polyclonal antibody

Cited in 9 papers
#19851-1-AP
View Evidence →
Cell Signaling Technology

Vti1a (D8U3M) Rabbit Monoclonal Antibody

Cited in 8 papers
#14764$161,351
View Evidence →
Cell Signaling Technology

CUEDC2 Antibody

Cited in 8 papers
#12294$317
View Evidence →